Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

This randomized phase II trial studies how well low-dose ibuprofen in improving cognitive impairment in patients with cancer. Anti-inflammatory agents, such as ibuprofen, may slow the decline of cognitive processes and diseases involving the brain.

Interventions

Condition

Cognitive Impairment, Malignant Neoplasm

Trial Type

Comparative Effectiveness Research

See a list of participating sites on ClinicalTrials.gov


˄
BACK TO
TOP